1. Home
  2. LAB vs PRQR Comparison

LAB vs PRQR Comparison

Compare LAB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.71

Market Cap

326.2M

Sector

Industrials

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.92

Market Cap

262.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAB
PRQR
Founded
1999
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
326.2M
262.5M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
LAB
PRQR
Price
$0.71
$1.92
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$1.35
$7.25
AVG Volume (30 Days)
1.6M
784.4K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
61.54
N/A
EPS
0.26
N/A
Revenue
$101,937,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.63
$13.92
P/E Ratio
$2.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$1.33
52 Week High
$1.72
$3.10

Technical Indicators

Market Signals
Indicator
LAB
PRQR
Relative Strength Index (RSI) 36.43 57.04
Support Level $0.70 $1.37
Resistance Level $0.94 $1.99
Average True Range (ATR) 0.05 0.10
MACD -0.01 0.01
Stochastic Oscillator 0.25 75.00

Price Performance

Historical Comparison
LAB
PRQR

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: